SCHEMBL3608260

SCHEMBL3608260

O=C(Cn1ccc2cccc(-c3ccc(F)cc3)c21)NCCNCC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPK1 P28482 1/20 0.38
CNR2 P34972 1/20 0.37
NPY5R Q15761 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
MEN1 O00255 1/20 0.36
CYP2D6 P10635 1/20 0.36
KMT2A Q03164 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3606204 0.94 GRIN2B (0.41) GRIN2BSMN1; SMN2POLBRAB9AALDH1A1
SCHEMBL3597289 0.91 ALDH1A1 (0.41) SMN1; SMN2RAB9AALDH1A1HSD17B10MAPK1
SCHEMBL3605994 0.91 PIM1 (0.42) GRIN2BRAB9AALDH1A1HSD17B10MAPK1
SCHEMBL3608180 0.91 HTT (0.45) SMN1; SMN2RAB9AALDH1A1HSD17B10MAPK1
SCHEMBL3594707 0.91 NPC1 (0.41) SMN1; SMN2RAB9AALDH1A1HSD17B10MAPK1
SCHEMBL3605625 0.90 MGLL (0.38) SMN1; SMN2POLBALDH1A1HSD17B10MAPK1
SCHEMBL3589653 0.89 ROCK2 (0.38) SMN1; SMN2ALDH1A1HSD17B10MAPK1CNR2
SCHEMBL3605921 0.88 EPHX2 (0.41) SMN1; SMN2POLBRAB9AALDH1A1NPY5R
SCHEMBL3589635 0.86 NPY5R (0.41) GRIN2BSMN1; SMN2ALDH1A1HSD17B10MAPK1
SCHEMBL3596540 0.86 HSD17B10 (0.37) GRIN2BSMN1; SMN2POLBRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 GRIN2B 2950/4885SMN1; SMN2 4228/4885POLB 4479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.